Aura Biosciences, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for AURA, updated each market day.
AURA AI Sentiment
AI sees no strong directional signal for Aura Biosciences, Inc. Common Stock stock over the next 10 market days.
Prediction date: Oct. 30, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Aura Biosciences, Inc. Common Stock
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
Sector
Exchange
Market Cap
$652,821,772
Cap Tier
Employees
113
Headquarters
BOSTON, MA
Listed Since
Oct. 29, 2021
Website
AURA Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
AURA Volatility
Aura Biosciences, Inc. Common Stock has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
